Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

clear all | select all

Conference Years:

clear all | select all

Days Within Meeting:

clear all | select all

Conferences:

Availability:

clear all | select all

Participation Type:

clear all | select all

Topic Tracks*:

clear all | select all

Organ Site Tracks*:

  • Sort by:
  • Browse by:
<< first | < prev page: of 23 records per page: next > | last >>
pages: 1 2 3 4 5 ... 20 21 22 23 presentations: 1 to 25 of 554
Quantitative Approaches to Study Cancer Evolution and Heterogeneity
Tracking the arc of leukemia development from the beginning to the end
John E Dick
Univ. of Toronto, Toronto, ON, Canada
from AACR Annual Meeting 2019 on March 29, 2019 3:00 PM-5:00 PM
Quantitative Approaches to Study Cancer Evolution and Heterogeneity
Quantifying clonal dynamics through treatment and metastasis
Christina Curtis
Stanford University, Stanford, CA, United States
from AACR Annual Meeting 2019 on March 29, 2019 3:00 PM-5:00 PM
Quantitative Approaches to Study Cancer Evolution and Heterogeneity
Reconstructing the life history of cancers
Moritz Gerstung
European Bioinformatics Institute, Hinxton, Cambridgeshire, United Kingdom
from AACR Annual Meeting 2019 on March 29, 2019 3:00 PM-5:00 PM
Quantitative Approaches to Study Cancer Evolution and Heterogeneity
Evolution and heterogeneity in glioblastomas
Raul Rabadan
Columbia Univ. Medical Ctr., New York, NY, United States
from AACR Annual Meeting 2019 on March 29, 2019 3:00 PM-5:00 PM
From Cancer Genomics to the 3D Organization of the Genome
Cancer genetic and epigenetic alterations modify the genome topology
Elisa Oricchio
The Swiss Federal Institute of Technology Lausanne (EPFL), Lausanne, Switzerland
from AACR Annual Meeting 2019 on March 30, 2019 10:15 AM-12:15 PM
From Cancer Genomics to the 3D Organization of the Genome
  •  
  • Permission not
    granted for presentation
  •  
  •  
STAG2 mutations alter cohesin complex structure and function and provide therapeutic vulnerabilities in leukemia
Zuzana Tothova
Dana-Farber Cancer Institute, Boston, MA, United States
from AACR Annual Meeting 2019 on March 30, 2019 10:15 AM-12:15 PM
From Cancer Genomics to the 3D Organization of the Genome
  •  
  • Permission not
    granted for presentation
  •  
  •  
Structural variants in the cancer genome: A 3-D analysis
Jesse Dixon
Salk Institute, La Jolla, CA, United States
from AACR Annual Meeting 2019 on March 30, 2019 10:15 AM-12:15 PM
CAR-T, TCR, and Beyond: A Rapidly Evolving Revolution in Cancer Cellular Immunotherapeutics
CAR-T: A brief historical perspective
Joseph McGuirk
University of Kansas Medical Center, Westwood, KS, United States
from AACR Annual Meeting 2019 on March 30, 2019 1:00 PM-3:00 PM
CAR-T, TCR, and Beyond: A Rapidly Evolving Revolution in Cancer Cellular Immunotherapeutics
CAR-T cells in the clinic: Strategies to enhance efficacy and reduce toxicity
Saad J Kenderian
Mayo Clinic, Rochester, MN, United States
from AACR Annual Meeting 2019 on March 30, 2019 1:00 PM-3:00 PM
CAR-T, TCR, and Beyond: A Rapidly Evolving Revolution in Cancer Cellular Immunotherapeutics
Boutique to global regulatory approval: Constantly enhancing and improving engineered T cells
Bruce Levine
University Of Pennsylvania, Philadelphia, PA, United States
from AACR Annual Meeting 2019 on March 30, 2019 1:00 PM-3:00 PM
CAR-T, TCR, and Beyond: A Rapidly Evolving Revolution in Cancer Cellular Immunotherapeutics
  •  
  • Free
  • Coming soon
  • Some slides withheld
  •  
  •  
Lessons learned from comparing CD28 and 4-1BB-based CD19 CARs
Michel Sadelain
Mem. Sloan Kettering Cancer Ctr., New York, NY, United States
from AACR Annual Meeting 2019 on March 30, 2019 1:00 PM-3:00 PM
CAR-T, TCR, and Beyond: A Rapidly Evolving Revolution in Cancer Cellular Immunotherapeutics
  •  
  • Permission not
    granted for presentation
  •  
  •  
The future of CAR T: Allogeneic approach
Ewelina Morawa
CRISPR Therapeutics, Cambridge, MA, United States
from AACR Annual Meeting 2019 on March 30, 2019 1:00 PM-3:00 PM
Preleukemia and Clonal Hematopoiesis
The genetics and biology of clonal hematopoiesis
Benjamin L Ebert
Brigham & Women's Hospital, Boston, MA, United States
from AACR Annual Meeting 2019 on March 30, 2019 1:00 PM-3:00 PM
Preleukemia and Clonal Hematopoiesis
Prediction of AML evolution from age related clonal hematopoeisis
Liran Shlush
Weizmann Institute of Science, Rehovot, Israel
from AACR Annual Meeting 2019 on March 30, 2019 1:00 PM-3:00 PM
Preleukemia and Clonal Hematopoiesis
Clonal hematopoiesis in human aging and disease
Siddhartha Jaiswal
Stanford University, Stanford, CA, United States
from AACR Annual Meeting 2019 on March 30, 2019 1:00 PM-3:00 PM
ctDNA for Cancer Stratification, Monitoring, Clonal Tracking, MRD Detection, and Early Diagnosis
  •  
  • Permission not
    granted for presentation
  •  
  •  
ctDNA and cfDNA in body fluids as cancer biomarkers
Nickolas Papadopoulos
Johns Hopkins Sidney Kimmel Comp. Cancer Ctr., Baltimore, MD, United States
from AACR Annual Meeting 2019 on March 30, 2019 3:15 PM-5:15 PM
ctDNA for Cancer Stratification, Monitoring, Clonal Tracking, MRD Detection, and Early Diagnosis
ctDNA monitoring in hematologic malignancies
Sarah-Jane Dawson
Peter MacCallum Cancer Center, East Melbourne, Australia
from AACR Annual Meeting 2019 on March 30, 2019 3:15 PM-5:15 PM
ctDNA for Cancer Stratification, Monitoring, Clonal Tracking, MRD Detection, and Early Diagnosis
  •  
  • Permission not
    granted for presentation
  •  
  •  
ctDNA applications in both early and metastatic breast cancer
Carlos M Caldas
Cancer Research UK Cambridge Inst., Cambridge, United Kingdom
from AACR Annual Meeting 2019 on March 30, 2019 3:15 PM-5:15 PM
A Universal Cancer Biomarker: Are We There Yet?
A universal cancer biomarker: Are we there yet?
Matt Trau
The University of Queensland, Brisbane, Australia
from AACR Annual Meeting 2019 on March 31, 2019 7:00 AM-8:00 AM
High-Dimensional Single-Cell Mass Cytometry in Translational Cancer Research
High-dimensional single-cell mass cytometry in translational cancer research
Kara L. Davis
Stanford Univ., Stanford, CA, United States
from AACR Annual Meeting 2019 on March 31, 2019 7:00 AM-8:00 AM
Systems Biology and Cancer Immunology
Systematic approaches to improving personal cancer vaccines
Catherine J Wu
Dana-Farber Cancer Inst., Boston, MA, United States
from AACR Annual Meeting 2019 on March 31, 2019 1:00 PM-2:45 PM
Systems Biology and Cancer Immunology
Antigen-independent de novo prediction of cancer-associated immune repertoire
Bo Li
UT Southwestern Medical Center, Dallas, TX, United States
from AACR Annual Meeting 2019 on March 31, 2019 1:00 PM-2:45 PM
Systems Biology and Cancer Immunology
Comprehensive enumeration of immune cell populations in solid human tissue using MIBI
Michael Angelo
Stanford University School of Medicine, Palo Alto, CA, United States
from AACR Annual Meeting 2019 on March 31, 2019 1:00 PM-2:45 PM
The Evolving Tumor Microenvironment in Tumor Progression and Therapy Responses
Targeting the metastatic tumor microenvironment to limit cancer progression
Sheila A Stewart
Washington Univ., St. Louis, MO, United States
from AACR Annual Meeting 2019 on March 31, 2019 1:00 PM-2:45 PM
The Evolving Tumor Microenvironment in Tumor Progression and Therapy Responses
Pancreatic cancer fibroblast subtypes
David A Tuveson
Cold Spring Harbor Laboratory Cancer Ctr., Cold Spring Harbor, NY, United States
from AACR Annual Meeting 2019 on March 31, 2019 1:00 PM-2:45 PM
<< first | < prev page: of 23 records per page: next > | last >>
pages: 1 2 3 4 5 ... 20 21 22 23 presentations: 1 to 25 of 554